Nipple Aspirate Fluid in Detecting Breast Cancer
NCT03715959 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2
Last updated 2025-02-25
Summary
This trial studies nipple aspirate fluid in detecting breast cancer. Nipple aspirate fluid may better detect breast cancer earlier than current methods used for screening such as mammograms and breast examinations.
Conditions
- Anatomic Stage IA Breast Cancer AJCC v8
- Anatomic Stage IB Breast Cancer AJCC v8
- Anatomic Stage II Breast Cancer AJCC v8
- Anatomic Stage IIA Breast Cancer AJCC v8
- Anatomic Stage IIB Breast Cancer AJCC v8
- Anatomic Stage III Breast Cancer AJCC v8
- Anatomic Stage IIIA Breast Cancer AJCC v8
- Anatomic Stage IIIB Breast Cancer AJCC v8
- Anatomic Stage IIIC Breast Cancer AJCC v8
- Anatomic Stage IV Breast Cancer AJCC v8
- Estrogen Receptor Negative
- Healthy Subject
- HER2 Positive Breast Carcinoma
- HER2/Neu Negative
- Luminal A Breast Carcinoma
- Luminal B Breast Carcinoma
- Progesterone Receptor Negative
- Prognostic Stage I Breast Cancer AJCC v8
- Prognostic Stage IA Breast Cancer AJCC v8
- Prognostic Stage IB Breast Cancer AJCC v8
- Prognostic Stage II Breast Cancer AJCC v8
- Prognostic Stage IIB Breast Cancer AJCC v8
- Prognostic Stage III Breast Cancer AJCC v8
- Prognostic Stage IIIA Breast Cancer AJCC v8
- Prognostic Stage IIIB Breast Cancer AJCC v8
- Prognostic Stage IIIC Breast Cancer AJCC v8
- Prognostic Stage IV Breast Cancer AJCC v8
- Triple-Negative Breast Carcinoma
Interventions
- PROCEDURE
-
Aspiration of Breast
Undergo NAF
- PROCEDURE
-
Biospecimen Collection
Undergo NAF
Sponsors & Collaborators
-
Ohio State University Comprehensive Cancer Center
lead OTHER
Principal Investigators
-
William Carson, MD · Ohio State University Comprehensive Cancer Center
Study Design
- Allocation
- NA
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 40 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2020-12-10
- Primary Completion
- 2024-01-01
- Completion
- 2024-01-01
Countries
- United States
Study Locations
More Related Trials
-
Comparison of Biomarkers Based on Fine-Needle Aspiration in Women at Increased or Normal Risk of Breast Cancer
NCT00041353 ·Status: WITHDRAWN ·Phase: NA
-
Laser Spectroscopy of Breast Tissue Through a Needle Device
NCT00918788 ·Status: COMPLETED
-
Detecting Circulating Tumor Cells (CTCs) and Cell Free DNA (cfDNA) in Peripheral Blood of Breast Cancer (BC) Patients to Develop the Clinical Application for Early Detection and Diagnostics
NCT03511859 ·Status: UNKNOWN
-
MRI for Detecting Cancer in Women Who Are at High Risk of Developing Breast Cancer
NCT00003736 ·Status: COMPLETED ·Phase: NA
-
Breath Test to Predict Breast Cancer and Outcome of Mammography
NCT04755829 ·Status: UNKNOWN
-
Comprehensive Screening for Women at High Genetic Risk for Developing Breast Cancer
NCT00255060 ·Status: COMPLETED
-
Automated Method for Breast Cancer Detection
NCT03863522 ·Status: TERMINATED ·Phase: NA
-
A Trial of the ForeCYTE Breast Aspirator for Cytological Testing of Nipple Aspirate Fluid in Women 30-55 Years Old
NCT02539615 ·Status: WITHDRAWN ·Phase: PHASE3
-
ForeCYTE Breast Aspirator for Sample Collection and Cytological Testing of Nipple Aspirate Fluid
NCT02218385 ·Status: COMPLETED
-
Studying Biomarkers in Nipple Fluid, Urine, and Blood Samples From Women With Newly Diagnosed Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer and in Women at Risk of Developing Breast Cancer
NCT00897208 ·Status: COMPLETED
-
Detection of Aggressive Breast Tumors Using Tc-99m-NC100692
NCT00888589 ·Status: COMPLETED
-
Duct Endoscopy in Assessing Cellular Atypia in the Breast Duct Fluid of Women With a Genetic Risk for Breast Cancer
NCT00082979 ·Status: UNKNOWN ·Phase: PHASE2
-
Validation of Molecular Diagnostic Assays to Detect Cancer Biomarkers in Blood & Primary Tumor in ER+/HER2- MBC
NCT04480814 ·Status: COMPLETED
-
Diagnostic Performance of Positron Emission Mammography in Breast Cancer
NCT06792591 ·Status: NOT_YET_RECRUITING
-
The Breast Duct: Pilot Study of Genomic Sequencing of Exfoliated Ductal Cells Obtained Through Endoscopy and Lavage
NCT02121873 ·Status: COMPLETED
-
A Prospective Validation Study of a Rapid Point-of-Care Breath Test for Breast Cancer
NCT02888366 ·Status: COMPLETED
-
Pilot Study of Oxytocin and microRNA Identification in NAF, Serum, and Tissue in Women With Breast Cancer
NCT02127073 ·Status: TERMINATED ·Phase: PHASE2
-
The Use of Deep Inspiration Breath Hold and Prone Irradiation to Decrease Cardiac Radiation Exposure
NCT03375892 ·Status: COMPLETED ·Phase: NA
-
Identification of Biomarkers in Women at High Risk or Average Risk of Breast Cancer
NCT00897416 ·Status: COMPLETED
-
Abbreviated Breast MRI in Cancer Detection
NCT03870659 ·Status: COMPLETED
-
Study of Breast Tissue in Women Not Previously Diagnosed With Breast Cancer Who Are Undergoing Fine Needle Aspiration
NCT00896636 ·Status: UNKNOWN
-
S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer
NCT03723928 ·Status: RECRUITING ·Phase: NA
-
A Multicenter Breast Cancer Biospecimen Registry
NCT02712645 ·Status: UNKNOWN
-
An Evaluation of Stereoscopic Digital Mammography for Earlier Detection of Breast Cancer and Reduced Rate of Recall
NCT00208871 ·Status: COMPLETED ·Phase: NA
-
Identifying Patterns in the Breath of Individuals With Breast Cancer
NCT06512350 ·Status: RECRUITING